Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	0.9% normal saline (control)	-	-	-	-	1件: 299 💬
2	Active control	-	-	-	-	1件: 13 💬
3	Amitriptyline, fluoxetine and tramadol alone (control group)	Amitriptyline	6件: D00326, D00809, D00823, D01355, D07448, D08623 💬	3件: OPRM1, SLC6A2, SLC6A4 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 78 💬
4	Behavioral: assessment of severity of icd (impulse control disorders)	-	-	-	-	1件:  6  💬
5	Behavioral: attention control	-	-	-	-	1件:  6  💬
6	Behavioral: healthy age-matched controls	-	-	-	-	1件:  6  💬
7	Behavioral: low-impact exercise control	-	-	-	-	1件:  6  💬
8	Behavioral: protein and calorie controlled diet	-	-	-	-	1件: 251 💬
9	Boots high strength garlic odour controlled	Garlic	-	-	-	1件: 299 💬
10	Bpr277 ointment (controlled application)	-	-	-	-	1件: 160 💬
11	Coenzyme q-10 in normal control subjects	Ubidecarenone	1件: D01065 💬	-	-	1件: 86 💬
12	Control	-	-	-	-	4件:  6 , 46, 168, 299 💬
13	Control group	-	-	-	-	3件:  2 , 46, 70 💬
14	Control group 0.9% isotonic saline	-	-	-	-	1件: 299 💬
15	Control intervention (no dexamethasone)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
16	Control multivitamin	-	-	-	-	1件: 299 💬
17	Controlled-release levodopa / carbidopa	Carbidopa	2件: D00059, D00558 💬	6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬	16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	1件:  6  💬
18	Cornstarch control	Starch, corn	1件: D05297 💬	-	-	1件: 90 💬
19	Diagnostic test: blood drawing in healthy controls	-	-	-	-	1件: 65 💬
20	Diazoxide choline controlled-release tablet	Choline	2件: D00294, D07690 💬	2件: ABCC8, KCNJ11 💬	4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus	1件: 193 💬
21	Epilim chrono 200 controlled released tablets	-	-	-	-	1件: 256 💬
22	Epilim chrono 300 controlled released tablets	-	-	-	-	1件: 256 💬
23	Epilim chrono 500 controlled released tablets	-	-	-	-	1件: 256 💬
24	Group 1- control diet	-	-	-	-	1件: 97 💬
25	High dose vehicle control	-	-	-	-	1件: 46 💬
26	Histamine	Histamine	1件: D08040 💬	4件: HRH1, HRH2, HRH3, HRH4 💬	4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	1件: 13 💬
27	Infliximab control	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
28	Levodopa cr (controlled release)	Levodopa	1件: D00059 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
29	Low dose vehicle control	-	-	-	-	1件: 46 💬
30	Other: control	-	-	-	-	8件:  6 , 19, 70, 75, 85, 97, 162, 193 💬
31	Other: control diet	-	-	-	-	1件: 96 💬
32	Other: control group	-	-	-	-	1件:  2  💬
33	Other: control group(normal saline)	-	-	-	-	1件: 97 💬
34	Other: control wound treatment	-	-	-	-	1件: 36 💬
35	Other: controlled environment tests (series of tasks of everyday life)	-	-	-	-	1件:  6  💬
36	Other: controls primary cervical dystonia (trihexyphenidyl)	Trihexyphenidyl	2件: D00787, D08638 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件:  6  💬
37	Other: dyt 1 dystonia (healthy control)	-	-	-	-	1件:  6  💬
38	Other: healthy controls	-	-	-	-	1件: 63 💬
39	Other: histamine	Histamine	1件: D08040 💬	4件: HRH1, HRH2, HRH3, HRH4 💬	4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	1件: 13 💬
40	Other: historical control	-	-	-	-	1件:  2  💬
41	Other: low blood pressure control	-	-	-	-	1件: 67 💬
42	Other: no msdmds therapy (control)	-	-	-	-	1件: 13 💬
43	Other: normal (control) diet	-	-	-	-	1件: 240 💬
44	Other: observational control	-	-	-	-	1件: 13 💬
45	Other: reaction time and postural control	-	-	-	-	1件: 299 💬
46	Other: standard blood pressure control	-	-	-	-	1件: 67 💬
47	Oxycodone by patient-controlled analgesia (pca)	Oxycodone	3件: D03783, D05312, D05462 💬	3件: OPRD1, OPRK1, OPRM1 💬	5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
48	Procedure: control group	-	-	-	-	1件: 34 💬
49	Ropinirole controlled-release (requip cr) for rls	Ropinirole	2件: D00784, D08489 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	1件:  6  💬
50	Sinemet® controlled release (carbidopa/levodopa)	Carbidopa	2件: D00059, D00558 💬	6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬	16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway	1件:  6  💬
51	Vehice control	-	-	-	-	1件: 96 💬
52	Vehicle control	-	-	-	-	1件: 53 💬

先頭へ